SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-22-010238
Filing Date
2022-03-15
Accepted
2022-03-15 08:51:29
Documents
87
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cogt-10k_20211231.htm   iXBRL 10-K 2494105
2 EX-4.1 cogt-ex41_7.htm EX-4.1 47626
3 EX-10.1 cogt-ex101_639.htm EX-10.1 63295
4 EX-10.4 cogt-ex104_638.htm EX-10.4 20073
5 EX-21.1 cogt-ex211_10.htm EX-21.1 6453
6 EX-23.1 cogt-ex231_13.htm EX-23.1 2575
7 EX-31.1 cogt-ex311_12.htm EX-31.1 9984
8 EX-31.2 cogt-ex312_9.htm EX-31.2 9964
9 EX-32.1 cogt-ex321_14.htm EX-32.1 6002
10 EX-32.2 cogt-ex322_6.htm EX-32.2 5980
11 GRAPHIC grdcseqcwpmf000001.jpg GRAPHIC 25284
12 GRAPHIC grdcseqcwpmf000005.jpg GRAPHIC 87204
13 GRAPHIC grdcseqcwpmf000004.jpg GRAPHIC 59077
14 GRAPHIC grdcseqcwpmf000003.jpg GRAPHIC 23020
15 GRAPHIC grdcseqcwpmf000002.jpg GRAPHIC 26930
16 GRAPHIC grdcseqcwpmf000007.jpg GRAPHIC 80866
17 GRAPHIC grdcseqcwpmf000006.jpg GRAPHIC 129797
  Complete submission text file 0001564590-22-010238.txt   10709128

Data Files

Seq Description Document Type Size
18 XBRL TAXONOMY EXTENSION SCHEMA cogt-20211231.xsd EX-101.SCH 69507
19 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cogt-20211231_cal.xml EX-101.CAL 59034
20 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cogt-20211231_def.xml EX-101.DEF 265550
21 XBRL TAXONOMY EXTENSION LABEL LINKBASE cogt-20211231_lab.xml EX-101.LAB 543532
22 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cogt-20211231_pre.xml EX-101.PRE 431313
81 EXTRACTED XBRL INSTANCE DOCUMENT cogt-10k_20211231_htm.xml XML 1628521
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38443 | Film No.: 22739258
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences